quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:15·137d
SECFiling
Addex Therapeutics Ltd logo

SEC Form EFFECT filed by Addex Therapeutics Ltd

ADXN· Addex Therapeutics Ltd
Health Care
Original source

Companies

  • ADXN
    Addex Therapeutics Ltd
    Health Care

Recent analyst ratings

  • Jul 31UpdateH.C. Wainwright$30.00
  • Feb 11UpdateHC Wainwright & Co.$21.00

Related

  • SEC19h
    SEC Form 6-K filed by Addex Therapeutics Ltd
  • PR1d
    Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026
  • SEC2d
    SEC Form 6-K filed by Addex Therapeutics Ltd
  • PR3d
    Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model
  • INSIDER29d
    SEC Form 3 filed by new insider Mills Roger
  • INSIDER29d
    SEC Form 3 filed by new insider Lawton Vincent Michael
  • INSIDER29d
    SEC Form 3 filed by new insider Teyssedou Lenaic Nathanael
  • INSIDER29d
    SEC Form 3 filed by new insider Kalinichev Mikhail
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022